Literature DB >> 9415022

Modulation in vitro of human natural cytotoxicity, lymphocyte proliferative response to mitogens and cytokine production by essential fatty acids.

P Purasiri1, A Mckechnie, S D Heys, O Eremin.   

Abstract

Essential fatty acids (EFA) have been shown in animal studies to have a differential effect on various aspects of immune reactivity. However, there have been few studies in humans. Therefore, we elected to investigate the effects of a variety of EFA [gamma-linolenic acid (GLA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)] in vitro on human blood lymphocyte reactivity, cytokine secretion and natural cytotoxicity. The proliferative response to polyclonal mitogens (phytohaemagglutinin, pokeweed mitogen, concanavalin A), as measured by [3H]thymidine incorporation into newly synthesized lymphocytes, was inhibited (P < 0.05) by all EFAs tested, in a dose-dependent manner (3-15 micrograms/ml). The greatest inhibition of proliferation was caused by EPA and DHA. Similarly, EPA, DHA and GLA significantly reduced cytotoxic activity [expressed as lytic units, using 51 chromium-release assays natural killer (NK) (K562 cells) and lymphokine-activated (LAK) (Daudi cells) cells] (P < 0.05) in a concentration-dependent manner (5-50 micrograms/ml), without affecting cell viability. EPA and DHA exhibited greater suppression than GLA. Furthermore, the inhibition of cell proliferation and suppression of natural cytotoxicity was associated with marked decrease in cytokine [interleukin-1 (IL-1), IL-2, tumour necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma)] production in vitro. Our findings demonstrate that EFAs (GLA, EPA, DHA) have the potential to inhibit significantly various aspects of human lymphocyte cell-mediated and humoral immune reactivities.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9415022      PMCID: PMC1364054          DOI: 10.1046/j.1365-2567.1997.d01-2308.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  40 in total

1.  The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells.

Authors:  S Endres; R Ghorbani; V E Kelley; K Georgilis; G Lonnemann; J W van der Meer; J G Cannon; T S Rogers; M S Klempner; P C Weber
Journal:  N Engl J Med       Date:  1989-02-02       Impact factor: 91.245

Review 2.  The interleukins.

Authors:  S B Mizel
Journal:  FASEB J       Date:  1989-10       Impact factor: 5.191

3.  Fatty acid metabolism in human lymphocytes. II. Activation of fatty acid desaturase-elongase systems during blastic transformation.

Authors:  A Anel; J Naval; B González; J Uriel; A Piñeiro
Journal:  Biochim Biophys Acta       Date:  1990-06-14

4.  Immune regulation by leukotriene B4.

Authors:  M Rola-Pleszczynski; L Gagnon; P A Chavaillaz
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

Review 5.  Fatty acid metabolism of isolated mammalian cells.

Authors:  M D Rosenthal
Journal:  Prog Lipid Res       Date:  1987       Impact factor: 16.195

Review 6.  Essential fatty acids and immune response.

Authors:  D Hwang
Journal:  FASEB J       Date:  1989-07       Impact factor: 5.191

7.  Prostaglandin E precursor fatty acids inhibit human IL-2 production by a prostaglandin E-independent mechanism.

Authors:  D Santoli; R B Zurier
Journal:  J Immunol       Date:  1989-08-15       Impact factor: 5.422

8.  The international standard for human interleukin-2. Calibration by international collaborative study.

Authors:  A J Gearing; R Thorpe
Journal:  J Immunol Methods       Date:  1988-11-10       Impact factor: 2.303

Review 9.  Biology of interleukin 1.

Authors:  C A Dinarello
Journal:  FASEB J       Date:  1988-02       Impact factor: 5.191

10.  A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone.

Authors:  S A Rosenberg; M T Lotze; L M Muul; A E Chang; F P Avis; S Leitman; W M Linehan; C N Robertson; R E Lee; J T Rubin
Journal:  N Engl J Med       Date:  1987-04-09       Impact factor: 91.245

View more
  21 in total

1.  Nutrigenetic response to omega-3 fatty acids in obese asthmatics (NOOA): rationale and methods.

Authors:  Jason E Lang; Edward B Mougey; Hooman Allayee; Kathryn V Blake; Richard Lockey; Yan Gong; Jobayer Hossain; Kelleigh Killen; John J Lima
Journal:  Contemp Clin Trials       Date:  2013-01-06       Impact factor: 2.226

2.  Enteral nutritional supplementation with key nutrients in patients with critical illness and cancer: a meta-analysis of randomized controlled clinical trials.

Authors:  S D Heys; L G Walker; I Smith; O Eremin
Journal:  Ann Surg       Date:  1999-04       Impact factor: 12.969

Review 3.  Modulation of immune cell function by polyunsaturated fatty acids.

Authors:  Brian Sweeney; Prem Puri; Denis J Reen
Journal:  Pediatr Surg Int       Date:  2005-04-16       Impact factor: 1.827

Review 4.  The intestinal mucosa as a target for dietary polyunsaturated fatty acids.

Authors:  A Donnet-Hughes; E J Schiffrin; M E Turini
Journal:  Lipids       Date:  2001-09       Impact factor: 1.880

Review 5.  Polyunsaturated fatty acids, inflammation, and immunity.

Authors:  P C Calder
Journal:  Lipids       Date:  2001-09       Impact factor: 1.880

6.  Influence of dietary supplementation with long-chain n-3 or n-6 polyunsaturated fatty acids on blood inflammatory cell populations and functions and on plasma soluble adhesion molecules in healthy adults.

Authors:  F Thies; E A Miles; G Nebe-von-Caron; J R Powell; T L Hurst; E A Newsholme; P C Calder
Journal:  Lipids       Date:  2001-11       Impact factor: 1.880

7.  Distal proctocolitis and n-3 polyunsaturated fatty acids (n-3 PUFAs): the mucosal effect in situ.

Authors:  Y Z Almallah; S W Ewen; A El-Tahir; N A Mowat; P W Brunt; T S Sinclair; S D Heys; O Eremin
Journal:  J Clin Immunol       Date:  2000-01       Impact factor: 8.317

Review 8.  Prenatal fatty acid status and immune development: the pathways and the evidence.

Authors:  Susan L Prescott; Janet A Dunstan
Journal:  Lipids       Date:  2007-03-13       Impact factor: 1.880

9.  Dihomo-gamma-linolenic acid inhibits tumour necrosis factor-alpha production by human leucocytes independently of cyclooxygenase activity.

Authors:  Maaike M B W Dooper; Boet van Riel; Yvo M F Graus; Laura M'Rabet
Journal:  Immunology       Date:  2003-11       Impact factor: 7.397

10.  Effect of linoleic acid and gamma-linolenic acid on tear production, tear clearance and on the ocular surface after photorefractive keratectomy.

Authors:  Angelo Macrì; Sebastiano Giuffrida; Valentina Amico; Michele Iester; Carlo Enrico Traverso
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-05-27       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.